X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-23 | OCUL | Nayak Sanjay | Chief Strategy Officer | S - Sale | $9.02 | -1,832 | 176,194 | -1% | -$16,525 | ||||||
2024-08-23 | OCUL | Dugel Pravin | See Remarks | S - Sale | $9.02 | -20,880 | 812,473 | -3% | -$188,338 | ||||||
2024-05-23 | OCUL | Nayak Sanjay | Chief Strategy Officer | S - Sale | $5.84 | -2,274 | 178,026 | -1% | -$13,280 | ||||||
2024-05-23 | OCUL | Dugel Pravin | See Remarks | S - Sale | $5.79 | -21,626 | 833,353 | -3% | -$125,215 | ||||||
2024-02-26 | OCUL | Summer Road LLC | 10% | P - Purchase | $7.52 | +930,851 | 8,591,401 | +12% | +$7,000,000 | ||||||
| D | 2024-02-05 | OCUL | White Christopher G | Chief Business Officer | S - Sale+OE | $4.86 | -5,910 | 123,689 | -5% | -$28,723 | |||||
| D | 2024-02-05 | OCUL | Strassburger Philip C. | GC | S - Sale+OE | $4.86 | -6,029 | 161,493 | -4% | -$29,301 | |||||
| D | 2024-02-05 | OCUL | Ozden Rabia Gurses | Chief Medical Officer | S - Sale+OE | $4.86 | -6,346 | 153,054 | -4% | -$30,842 | |||||
| D | 2024-02-05 | OCUL | Notman Donald | CFO | S - Sale+OE | $4.86 | -6,212 | 195,356 | -3% | -$30,190 | |||||
| D | 2024-02-05 | OCUL | Mattessich Antony C. | Pres, CEO | S - Sale+OE | $4.86 | -19,642 | 595,201 | -3% | -$95,460 | |||||
2024-01-31 | OCUL | Notman Donald | CFO | S - Sale | $4.95 | -6,433 | 139,932 | -4% | -$31,843 | ||||||
2024-01-31 | OCUL | Ozden Rabia Gurses | Chief Medical Officer | S - Sale | $4.95 | -7,764 | 92,767 | -8% | -$38,432 | ||||||
2024-01-31 | OCUL | Strassburger Philip C. | GC | S - Sale | $4.95 | -6,831 | 109,218 | -6% | -$33,813 | ||||||
2024-01-31 | OCUL | White Christopher G | Chief Business Officer | S - Sale | $4.95 | -5,147 | 89,619 | -5% | -$25,478 | ||||||
2024-01-31 | OCUL | Mattessich Antony C. | Pres, CEO | S - Sale | $4.95 | -18,338 | 434,443 | -4% | -$90,773 | ||||||
2023-12-14 | OCUL | Summer Road LLC | 10% | P - Purchase | $3.25 | +1,538,461 | 7,660,550 | +25% | +$4,999,998 | ||||||
2023-08-30 | OCUL | Mattessich Antony C. | Pres, CEO | P - Purchase | $3.81 | +6,500 | 452,781 | +1% | +$24,765 | ||||||
2023-07-07 | OCUL | Ozden Rabia Gurses | Chief Medical Officer | S - Sale | $4.93 | -832 | 100,531 | -1% | -$4,102 | ||||||
2023-02-06 | OCUL | White Christopher G | Chief Business Officer | S - Sale | $4.24 | -5,829 | 94,766 | -6% | -$24,715 | ||||||
2023-02-06 | OCUL | Ozden Rabia Gurses | Chief Medical Officer | S - Sale | $4.24 | -6,416 | 101,363 | -6% | -$27,204 | ||||||
2023-02-06 | OCUL | Notman Donald | CFO | S - Sale | $4.24 | -6,476 | 139,387 | -4% | -$27,458 | ||||||
2023-02-06 | OCUL | Strassburger Philip C. | GC | S - Sale | $4.24 | -6,181 | 109,071 | -5% | -$26,207 | ||||||
2023-02-06 | OCUL | Mattessich Antony C. | Pres, CEO | S - Sale | $4.24 | -19,669 | 446,281 | -4% | -$83,397 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |